We retrospectively compared patients receiving remifentanil with patients receiving sufentanil undergoing fasttrack cardiac surgery. After 1:1 propensity score matching there were 609 patients in each group. The sufentanil group had a significantly longer mean (SD) ventilation time compared with the remifentanil group; 122 (59) vs. 80 (44) min, p < 0.001 and longer mean (SD) length of stay in the recovery area; 277 (77) vs. 263 (78) min, p = 0.002. The sufentanil group had a lower mean (SD) visual analogue pain score than the remifentanil group; 1.5 (1.2) vs. 2.4 (1.5), p < 0.001 and consumed less mean (SD) piritramide (an opioid analgesic used in our hospital); 2.6 (4.7) vs. 18.9 (7.3) mg, p < 0.001. The results of our study show that although remifentanil was more effective in reducing time to tracheal extubation and length of stay in the recovery area, there was an increased requirement for postoperative analgesia when remifentanil was used.
Introduction
Fast-track pathways have become an integral part of cardiac anaesthesia in order to allow for rapid tracheal extubation and to reduce intensive care unit length of stay, without affecting the quality of care [1] . It may lead to a more efficient use of resources espeically if there is a shortage of intensive care unit (ICU) beds and increased demands by a more efficient use of resources [2] . It is popular due to its cost-effectiveness [3] . Different fast-track protocols have been developed for ICU or for specialised recovery areas. Fast-track pathways with the use of a recovery area [4] are effective in reducing time to tracheal extubation and ICU length of stay [1] . Although several studies have shown that the type of opioid plays a minor role in different fast-track protocols [5] [6] [7] , it has been difficult to compare studies due to the heterogeneity of 
Methods
This retrospective observational study was performed in a single university-affiliated heart centre, was approved by the local research ethical committee and individual patient consent was waived. In the period from February to July 2017, we were obliged to change opioid management within our standard fast-track protocol due to the unavailability of remifentanil. During this period, we decided to use a continuous sufentanil infusion instead. We included all consecutive cardiac surgery patients admitted to the recovery area during this time period. This group was compared with an historical group of patients from the same time period the previous year (February-July 2016) who had received a continuous remifentanil infusion according to our standard fast-track protocol [4] . Table 1 Weaning, extubation and transfer criteria for patients undergoing fast-track anaesthesia.
Weaning criteria:
• Train-of-four (TOF) ratio > 0. 9 • Pressure support ventilation; PS 10-12 cmH 2 O, PEEP 0-
• Arterial blood gases; PaO 2 ≥ 13.3 kPa, PaCO 2 ≤ 5.8 kPa
, no acidosis
• Chest drainage ≤ 200 ml in 1st h, ≤ 100 ml in 2nd h then ≤ 50 ml.h
À1
Criteria for tracheal extubation:
• 
Results
There were 622 patients in the sufentanil group and 679 patients in the remifentanil group. Eighty-three patients were excluded during the 1:1 propensity score matching process, resulting in two equal groups, each containing 609 patients (Fig. 1) . Baseline characteristics and operative data for patients included in the study are shown in Table 2 . , with a mean (SD) total consumption of 3.100 (0.100) lg.kg
À1
. There was no correlation between total sufentanil consumption and ventilation time (r = 0.174). There were no differences between the groups in terms of postoperative complications (Table 4) . 
Discussion
We have demonstrated that a remifentanil infusion in cardiac surgery patients managed in a specialised recovery area using a fast-track protocol resulted in a significantly shorter ventilation time and length of stay in the recovery area compared with patients who received a sufentanil infusion. However, the remifentanil group required more postoperative analgesia than the sufentanil group in order to reach the targeted visual analogue pain score.
Remifentanil group patients had longer hospital stays, but there was no difference in intermediate care unit length of stay. There was no difference in fast-track failure rate, Nu-DESC, nursing delirium screening scale. a n = 483 b n = 321. 80 min for the remifentanil group and 261 vs. 122 min for the sufentanil group. We found that the longer the ventilation time, the smaller the difference between groups (Fig. 3) . The explanation for shorter ventilation times in our study might be differences in our fast-track protocol. Saturday afternoon, whereas our recovery area was closed overnight. Grass et al. [8] showed that limited opening hours led to decreased ventilation time. Differences in sufentanil dosages could be another explanation, however,
we were unable to demonstrate a statistically significant correlation between total amount of sufentanil administered and ventilation time. This is in agreement with a study comparing different doses of sufentanil in fast-track patients which showed no difference in ventilation time [9] .
Different studies have used comparable sufentanil dosages to ours but have reported much longer ventilation times.
This supports our hypothesis that it is not the specific opioid, or the amount of opioid given, but the fast-track protocol itself that makes the difference [6, 10] .
The increased requirement for postoperative analgesia in the form of piritramide in the remifentanil group is in agreement with previous studies [5, 6, 11] . This may be although Gerlach et al. [10] did not find any differences in repeated pain score measurements during the first 12 h postoperatively. In our study, the need for PCA due to high analgesic requirement caused by severe pain was comparable between the two groups, both during and after recovery area stay. In our study, fast-track failure was defined as any unplanned transfer of the fast-track patient from recovery area directly to the ICU or a return to the operating theatre.
There was a comparably low fast-track failure rate of 8% in both groups. This is in agreement with Lison et al. [6] who excluded approximately 10% patients in each of their groups due to failure in completion of the fast-track pathway. In contrast to Lison et al. [6] , we did not find a high incidence of postoperative nausea and vomiting in our remifentanil group. This may be due to our postoperative nausea and vomiting prophylaxis strategy and a recent systematic review supports our results [11] . We did not find any differences between our groups in the incidence of postoperative delirium, assessed before transfer from the recovery area, suggesting that the type of opioid per se is not a risk factor for the development of postoperative delirium. This is in accordance with the findings of a prospective randomised study comparing the incidence of postoperative cognitive dysfunction (POCD) in cardiac surgical patients [12] . A ventilation time of more than 300 min, rather than the choice of opioid, was associated with POCD. This is in agreement with a recent study investigating causes of post-cardiac surgery delirium [13] .
The main limitation of our study is its retrospective design resulting in a risk of potential bias. This is especially true for the significant difference in length of hospital stay between the two groups and may be the result of 'immortal time bias', that is, the concept that overall improvements in patient care occur more recently. An advantage of this study is the large number of patients included; it enabled us to detect even small differences in ventilation time.
In conclusion, although ventilation time and recovery area length of stay were shorter in the remifentanil group, sufentanil may be superior to remifentanil because it provided improved analgesia and resulted in a shorter hospital length of stay. However, we believe that a detailed and time-directed weaning protocol is more important than the use of a specific opioid for fast-track cardiac surgery patients.
